Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404898 · ClinicalTrials.gov registry record
NYU/Bellevue WTC Health Impacts Research Registry
A clinical trial of Exposure to World Trade Center Dust, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 40,000
- Enrollment target
- 1
- Study location
NCT00404898 is a study of Exposure to World Trade Center Dust that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 40,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00404898, a study of Exposure to World Trade Center Dust, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 40,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations are recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition. In addition, there is collaboration with the Charles B. Wang Community Health Center and the centers involved in the ongoing WTC Workers and Volunteer Medical Screening and Monitoring Program. We would now like to access the data from this treatment program to create a NYU/Bellevue WTC Health Impacts Research Registry to increase knowledge about the health effects of exposure to World Trade Center dust.
Conditions Studied
Study Locations (1)
New York
- NYU School of Medicine/Bellevue Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2007-12 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00404898
The ClinicalTrials.gov registry entry for NCT00404898 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Exposure to World Trade Center Dust appearing as the primary indexed condition, and to 0 interventions.
NCT00404898 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00404898 about?
NCT00404898 is a clinical study titled "NYU/Bellevue WTC Health Impacts Research Registry". The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the W...
What is the current status of trial NCT00404898?
This trial is currently recruiting. The enrollment target is 40,000 participants. The study started on 2007-12. Estimated completion is 2026-09.
What conditions does trial NCT00404898 study?
This clinical trial studies the following conditions: Exposure to World Trade Center Dust.
Who is sponsoring clinical trial NCT00404898?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00404898 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.